Raffles Medical Group reported a 9.6% decline in net profit for the first half of 2026, ending at S$29 million for the period through June 30.
The result marks a drop from the S$32 million recorded in the same period last year, reflecting headwinds across parts of the healthcare provider's portfolio.
Despite the overall profit contraction, the company's hospital services division continued to record earnings growth, providing a counterbalance to softer performance in other segments.
The divergence highlights the varying demand dynamics across outpatient and inpatient care models in Singapore's healthcare sector.
The results come as investors monitor how regional healthcare providers are navigating cost pressures and shifting patient volumes.
Raffles Medical's performance will be watched for signs of margin stability as the company moves into the second half of the year.